Lurasidone Hcl
Brand name: Latuda
Rank #94 of 500 drugs by total cost
$190.9M
Total Cost
254,237
Total Claims
$190.9M
Total Cost
9,984
Prescribers
$751
Cost per Claim
12,069
Beneficiaries
281,069
30-Day Fills
$19K
Avg Cost/Provider
25
Avg Claims/Provider
About Lurasidone Hcl
Lurasidone Hcl (sold as Latuda) was prescribed 254,237 times by 9,984 Medicare Part D providers in 2023, costing the program $190.9M. At $751 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
| 94 | Lurasidone Hcl (Latuda) | $190.9M | 254,237 |
| 95 | Darolutamide (Nubeqa) | $188.8M | 14,375 |
| 96 | Fluticasone Propionate (Fluticasone Propionate) | $187.5M | 5,343,836 |
| 97 | Hydrocodone/Acetaminophen (Hydrocodone-Acetaminophen) | $185.6M | 8,496,609 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology